Bellenie, Benjamin Richard,Bloomfield, Graham Charles,Bruce, Ian,Culshaw, Andrew James,Hall, Edward Charles,Hollingworth, Gregory,Neef, James,Spendiff, Matthew,Watson, Simon James
申请号：
AU2019210602
公开号：
AU2019210602A1
申请日:
2019.08.01
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
#$%^&*AU2019210602A120190822.pdf#####l:1 dar nterwovn NRPortbl DCC DAR 16329028_l.docx-19/01/2018 Abstract The present invention provides compounds of formula (1) N NH2 E Y R2 O=S=o NR4 which inhibit the activity of PI 3-kinase gamma isoform, which are useful for the treatment of diseases mediated by the activation of PI 3-kinase gamma isoform.
